Investigation into cell therapies is growing at an exponential rate across the pharma industry. In this infographic, we display the number and types of cell therapies currently in the R&D pipeline, with a particular analysis of CAR T
cell therapy.
On Thursday 23 June 2016, the people of the UK voted to leave the EU, by a winning margin of 3.8%. There began the UK’s long and eventful route to leave, scheduled for Friday 29 March.
In this immersive infographic we mark important milestones the UK life-sciences sector has seen in this near 3-year period, and the events unfolding for the UK’s journey out of the EU.
Find out about the top pharma M&A's over the last 7 years, and which countries are leading the way.
YOU MIGHT ALSO LIKE..
Marketing
Agility to Stay Relevant
Digital transformation is no easy task, but we are not entering a digital era — we are in one. We look outside the industry for inspiration and examine creative strategies to engage colleagues in the future.
Medical Affairs
The History of
Medical Affairs
Over the years, the medical affairs role has truly blossomed, but what caused these changes and how will it continue to evolve?
Patients
The Patient Will See
You Now
Pharma’s traditional drug development line is proving malleable: one day the patient may be sitting right at the front of it. As the future creeps closer, how can pharma see this shift as an opportunity for action and innovation?